[1]ZHANG L, WANG F, WANG L, et al.Prevalence of chronic kidney disease in China: a cross-sectional survey[J].Lancet, 2012, 379(9818):815-22
[2]ZHANG L, LONG J, JIANG W, et al.Trends in Chronic Kidney Disease in China[J].N Engl J Med, 2016, 375(9):905-6
[3]KONG X, TANG L, LIANG L, et al.Clinical outcomes following the surgery of new autologous arteriovenous fistulas proximal to the failed ones in end-stage renal disease patients: a retrospective cohort study[J].Ren Fail, 2019, 41(1):1036-44
[4]DU J, LIANG L, LIU S, et al.Neointimal hyperplasia in the inferior vena cava of adenine-induced chronic kidney disease rats with aortocaval fistulas[J].Clin Exp Nephrol, 2020, 24(11):1007-14
[5]GRASSI G, BIFFI A, SERAVALLE G, et al.Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis[J].J Hypertens, 2021, 39(3):408-16
[6]OSBORN J W, FOSS J D.Renal Nerves and Long-Term Control of Arterial Pressure[J].Compr Physiol, 2017, 7(2):263-320
[7]CONVERSE R L, JR.JACOBSEN T N,TOTO R D,et alSympathetic overactivity in patients with chronic renal failure[J].N Engl J Med, 1992, 327(27):1912-8
[8]TANAKA S, OKUSA M D.Crosstalk between the nervous system and the kidney[J].Kidney International, 2020, 97(3):466-76
[9]SATA Y, HEAD G A, DENTON K, et al.Role of the Sympathetic Nervous System and Its Modulation in Renal Hypertension. [J].Front Med (Lausanne), 2018, 5(/):82-/
[10]HAJARALSADAT HOSSEINI-DASTGERDI F K, ALI-ASGHAR POURSHANAZARI, AND MEHDI NEMATBAKHSH.Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors.[J].International Journal of Nephrology, 2022, 2022(/):11-/
[11]SATA Y, BURKE S L, WATSON A M D, et al.Differential sympathetic response to lesion-induced chronic kidney disease in rabbits[J].Kidney Int, 2020, 98(4):906-17
[12]ALPERS C E, IMREY P B, HUDKINS K L, et al.Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery[J].Journal of the American Society of Nephrology, 2017, 28(10):3076-88
[13]WOODSIDE K J, BELL S, MUKHOPADHYAY P, et al.Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study[J].Am J Kidney Dis, 2018, 71(6):793-801
[14]孔祥雷, 韩雯雯, 苏红.内皮细胞成分在尿毒症患者及健康人血清中的差异表达[J].国际泌尿系统杂志, 2017, 37(04):563-6
[15]KONG X, DU J, SU H, et al.Serum levels of the endothelial glycocalyx constituents and the early failure of forearm autologous arteriovenous fistulas in end-stage renal disease patients: a prospective cohort study[J].Int Urol Nephrol, 2020, 52(1):169-77
[16]BUBB K J, DRUMMOND G R, FIGTREE G A.New opportunities for targeting redox dysregulation in cardiovascular disease[J].Cardiovasc Res, 2020, 116(3):532-44
[17]FORSTERMANN U, XIA N, LI H.Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis[J].Circ Res, 2017, 120(4):713-35
[18]SHIU Y T, ROTMANS J I, GEELHOED W J, et al.Arteriovenous conduits for hemodialysis: how to better modulate the pathophysiological vascular response to optimize vascular access durability[J].Am J Physiol Renal Physiol, 2019, 316(5):F794-F806
[19]NGUYEN M, THANKAM F G, AGRAWAL D K.Sterile inflammation in the pathogenesis of maturation failure of arteriovenous fistula[J].J Mol Med (Berl), 2021, 99(6):729-41
[20]JUNCOS J P, GRANDE J P, KANG L, et al.MCP-1 contributes to arteriovenous fistula failure[J].J Am Soc Nephrol, 2011, 22(1):43-8
[21]MARTINEZ L, DUQUE J C, TABBARA M, et al.Fibrotic Venous Remodeling and Nonmaturation of Arteriovenous Fistulas[J].J Am Soc Nephrol, 2018, 29(3):1030-40
[22]FARIA M, DE PINHO M N.Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease.[J].Transl Res, 2021, 229(/):115-34
[23]LAMBIE M, BONOMINI M, DAVIES S J, et al.Insulin resistance in cardiovascular disease,uremia,and peritoneal dialysis[J].Trends Endocrinol Metab, 2021, 32(9):721-30
[24]BRAHMBHATT A, REMUZZI A, FRANZONI M, et al.The molecular mechanisms of hemodialysis vascular access failure[J].Kidney Int, 2016, 89(2):303-16
[25]KAUR J, YOUNG B E, FADEL P J.Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms. [J].Int J Mol Sci, 2017, 18(8):/-/
[26]CAO W, WU L, ZHANG X, et al.Sympathetic Overactivity in CKD Disrupts Buffering of Neurotransmission by Endothelium-Derived Hyperpolarizing Factor and Enhances Vasoconstriction[J].J Am Soc Nephrol, 2020, 31(10):2312-25
[27]FONKOUE I T, MARVAR P J, NORRHOLM S, et al.Symptom severity impacts sympathetic dysregulation and inflammation in post-traumatic stress disorder. [J].Brain Behav Immun, 2020, 83(/):260-9
[28]CHEN H, WANG R, XU F, et al.Renal denervation mitigates atherosclerosis in ApoE-- mice via the suppression of inflammation[J].Am J Transl Res, 2020, 12(9):5362-80
[29]LI Z, LI Q, WANG L, et al.Targeting mitochondria-inflammation circle by renal denervation reduces atheroprone endothelial phenotypes and atherosclerosis.[J].Redox Biol, 2021, 47(/):102156-/
[30]SADAGHIANLOO N, CONTENTI J, DARDIK A, et al.Role of Hypoxia and Metabolism in the Development of Neointimal Hyperplasia in Arteriovenous Fistulas. [J].Int J Mol Sci, 2019, 20(21):/-/
[31]POLHEMUS D J, GAO J, SCARBOROUGH A L, et al.Radiofrequency Renal Denervation Protects the Ischemic Heart via Inhibition of GRK2 and Increased Nitric Oxide Signaling[J].Circ Res, 2016, 119(3):470-80
[32]SHARP T E, 3RD, LEFER D J.Renal Denervation to Treat Heart Failure. [J].Annu Rev Physiol, 2021, 83(/):39-58
[33]REY J, TOWNSEND R R.Renal Denervation: A Review[J].Am J Kidney Dis, 2022, 80(4):527-35
[34]UNDERWOOD C F, HILDRETH C M, WYSE B F, et al.Uraemia: an unrecognized driver of central neurohumoral dysfunction in chronic kidney disease?[J].Acta Physiol (Oxf), 2017, 219(1):305-23
[35]JANG H S, KIM J, PADANILAM B J.Renal sympathetic nerve activation via alpha2-adrenergic receptors in chronic kidney disease progression[J].Kidney Res Clin Pract, 2019, 38(1):6-14
[36]OSBORN J W, TYSHYNSKY R, VULCHANOVA L.Function of Renal Nerves in Kidney Physiology and Pathophysiology. [J].Annu Rev Physiol, 2021, 83(/):429-50
[37]LI Q, DENG Y, LIU L, et al.Sympathetic Denervation Ameliorates Renal Fibrosis via Inhibition of Cellular Senescence.[J].Front Immunol, 2021, 12(/):823935-/
[38]KIUCHI M G, ESLER M D, FINK G D, et al.Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review[J].J Am Coll Cardiol, 2019, 73(23):3006-17
[39]CHEN T K, KNICELY D H, GRAMS M E.Chronic Kidney Disease Diagnosis and Management: A Review[J].JAMA, 2019, 322(13):1294-304
[40]BOHM M, KARIO K, KANDZARI D E, et al.Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre,randomised,sham-controlled trial[J].Lancet, 2020, 395(10234):1444-51
[41]SINGH R R, MCARDLE Z M, IUDICA M, et al.Sustained Decrease in Blood Pressure and Reduced Anatomical and Functional Reinnervation of Renal Nerves in Hypertensive Sheep 30 Months After Catheter-Based Renal Denervation[J].Hypertension, 2019, 73(3):718-27
[42]MAHFOUD F, MANCIA G, SCHMIEDER R, et al.Renal Denervation in High-Risk Patients With Hypertension[J].J Am Coll Cardiol, 2020, 75(23):2879-88
[43]MATHEW R O, BANGALORE S, LAVELLE M P, et al.Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review[J].Kidney Int, 2017, 91(4):797-807
[44]TANAKA S, OKUSA M D.Crosstalk between the nervous system and the kidney[J].Kidney Int, 2020, 97(3):466-76
[45]MOHANTA S K, PENG L, LI Y, et al.Neuroimmune cardiovascular interfaces control atherosclerosis[J].Nature, 2022, 605(7908):152-9
[46]CAPLICE N M, WANG S, TRACZ M, et al.Neoangiogenesis and the presence of progenitor cells in the venous limb of an arteriovenous fistula in the rat[J].Am J Physiol Renal Physiol, 2007, 293(2):F470-5
